Gideon Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Gideon Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,584	Closed	-$414K	–	95
2019 Q4	$414K	Buy	+1,584	New	+$417K	0.14%	189
2019 Q1	–	Sell	-2,126	Closed	-$395K	–	438
2018 Q4	$395K	Buy	+2,126	New	+$436K	0.16%	201
2018 Q3	–	Sell	-1,460	Closed	-$318K	–	412
2018 Q2	$318K	Sell	1,460 -2,686	-65%	-$553K	0.16%	243
2018 Q1	$794K	Buy	+4,146	New	+$765K	0.49%	38
2017 Q4	–	Sell	-1,572	Closed	-$244K	–	343
2017 Q3	$244K	Sell	1,572 -433	-22%	-$68.5K	0.24%	201
2017 Q2	$324K	Buy	+2,005	New	+$326K	0.36%	113
2017 Q1	–	Sell	-5,779	Closed	-$678K	–	451
2016 Q4	$678K	Buy	+5,779	New	+$659K	0.43%	37

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Gideon Capital Advisors's IDXX Position: Q1 2020 in Review

Gideon Capital Advisors sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 1,584 shares — an estimated $414K sold.

Gideon Capital Advisors first reported a position in IDXX in Q4 2016 and held it in 7 quarters. The position peaked at $794K in Q1 2018. 749 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

Gideon Capital Advisors reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
Gideon Capital Advisors sold 1,584 Idexx Laboratories shares in Q1 2020, an estimated $414K.
Gideon Capital Advisors first reported a position in Idexx Laboratories in Q4 2016 and held it in 7 quarters.
Gideon Capital Advisors's Idexx Laboratories position peaked at $794K in Q1 2018.
749 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Gideon Capital Advisors's 13F filing for Q1 2020.